Seres Therapeutics (1S90.MU) Q2 2026 Earnings

13MayConfirmed
Q1 2026
Next
-1.83
-1.74
-1.64
-1.55

Details

Expected EPS
-1.6059524
Actual EPS
N/A
Surprise EPS
1.61
Surprise Percent
+100%

Description

Seres Therapeutics (1S90.MU) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts